典型文献
Comments on National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)
文献摘要：
Melanoma remains a rare malignant tumor with high mortality and increasing incidence in China. Due to ethnic characteristics, acral and mucosal melanomas are the predominant subtypes in Asia, many research advances have been made in melanoma these years, especially for these two subtypes. In keeping with the development of key research on melanoma, the National Health Commission of the People's Republic of China organized experts to revise the Chinese guidelines for diagnosis and treatment of melanoma in 2021, and the National guidelines for diagnosis and treatment of melanoma 2022 in China (English version) was also updated (1).
文献关键词：
中图分类号：
作者姓名：
Jiaran Zhang;Lu Si;Jun Guo
作者机构：
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Melanoma&Sarcoma,Peking University Cancer Hospital&Institute,Beijing 100142,China
文献出处：
引用格式：
[1]Jiaran Zhang;Lu Si;Jun Guo-.Comments on National guidelines for diagnosis and treatment of melanoma 2022 in China (English version))[J].中国癌症研究（英文版）,2022(06):635-636
A类：
B类：
Comments,National,guidelines,diagnosis,treatment,China,English,version,Melanoma,remains,rare,malignant,tumor,high,mortality,increasing,incidence,Due,ethnic,characteristics,acral,mucosal,melanomas,predominant,subtypes,Asia,many,research,advances,have,been,made,these,years,especially,two,In,keeping,development,key,Health,Commission,People,Republic,organized,experts,revise,Chinese,was,also,updated
AB值：
0.592632
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
